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Background: Fatty acids (FA) play a critical role in energy homeostasis and metabolic diseases; in the context of
livestock species, their profile also impacts on meat quality for healthy human consumption. Molecular pathways
controlling lipid metabolism are highly interconnected and are not fully understood. Elucidating these molecular
processes will aid technological development towards improvement of pork meat quality and increased knowledge
of FA metabolism, underpinning metabolic diseases in humans.
Results: The results from genome-wide association studies (GWAS) across 15 phenotypes were subjected to an
Association Weight Matrix (AWM) approach to predict a network of 1,096 genes related to intramuscular FA
composition in pigs. To identify the key regulators of FA metabolism, we focused on the minimal set of transcription
factors (TF) that the explored the majority of the network topology. Pathway and network analyses pointed towards a
trio of TF as key regulators of FA metabolism: NCOA2, FHL2 and EP300. Promoter sequence analyses confirmed that
these TF have binding sites for some well-know regulators of lipid and carbohydrate metabolism. For the first time in a
non-model species, some of the co-associations observed at the genetic level were validated through co-expression at
the transcriptomic level based on real-time PCR of 40 genes in adipose tissue, and a further 55 genes in liver. In
particular, liver expression of NCOA2 and EP300 differed between pig breeds (Iberian and Landrace) extreme in
terms of fat deposition. Highly clustered co-expression networks in both liver and adipose tissues were observed.
EP300 and NCOA2 showed centrality parameters above average in the both networks. Over all genes, co-expression
analyses confirmed 28.9% of the AWM predicted gene-gene interactions in liver and 33.0% in adipose tissue. The
magnitude of this validation varied across genes, with up to 60.8% of the connections of NCOA2 in adipose tissue
being validated via co-expression.
Conclusions: Our results recapitulate the known transcriptional regulation of FA metabolism, predict gene
interactions that can be experimentally validated, and suggest that genetic variants mapped to EP300, FHL2, and
NCOA2 modulate lipid metabolism and control energy homeostasis in pigs.
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Figure 1 Hierarchical cluster analysis of the 15 phenotypes
analyzed in this study. Palmitic acid (C16), Stearic acid (C18),
Palmitoleic acid (C161N7), Oleic acid (C181N9), Linoleic acid
(C182N6), α-Linolenic acid (C183N3), Eicosadienoic acid (C202N6),
Eicosatrienoic acid (C202N6), Arachidonic acid (C204N6), Saturated
FA (SFA), Monounsaturated FA (MUFA), Polyunsaturated FA (PUFA),
Unsaturated indices (UI), Elongase activity (C202|C182), Percentage
intramuscular fat (IMF).
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Fatty acids (FA) are a major energy source and important
constituents of cell membranes, playing a relevant role as
cellular signaling molecules in various metabolic pathways,
including metabolic diseases [1]. Environmental and gen-
etic effects determining FA composition in pigs have been
the subject of many studies. Supporting a genetic influence
on FA composition moderate to high heritability estimates
have been reported [2,3]. However, the molecular process
controlling FA composition and metabolism is far from
being fully understood. Technological, nutritional and
organoleptic properties of pork meat quality are highly
dependent on lipid content and FA composition [4-6].
Thus, elucidating this molecular process could aid im-
prove meat quality for healthy human consumption and
increase knowledge of FA metabolism, underpinning
metabolic diseases. Pigs are important models for meta-
bolic diseases such as obesity, type II diabetes (T2D)
and atherosclerosis [7-10].
Molecular pathways controlling lipid metabolism are
highly interconnected. Also, they interact with other re-
lated pathways, such as carbohydrate metabolism and
energy homeostasis pathways. Together, these pathways
and its interactions constitute an essential metabolic net-
work for homeostatic control and normal organism devel-
opment [11]. In this context, a system biology approach
focused on the connections and functional interactions be-
tween genes that underpin these metabolic pathways is an
attractive alternative to the classical “single-gene-single-
trait” approach found in most genome-wide association
studies (GWAS) using single nucleotide polymorphisms
(SNP).
The main goal of this study was to employ a previously
described system biology approach termed Association
Weight Matrix (AWM) [12] and, based on a SNP-to-SNP
co-association evidence, infer a gene network for intra-
muscular (IMF) FA composition in pigs. This multi-trait
approach was applied to data from 15 phenotypes related
to FA composition and metabolism from an Iberian x
Landrace intercross. Iberian pigs are a local Mediterranean
breed extreme for obesity and appetite [13], whereas
Landrace is a lean international breed. The analysis of the
predicted gene network revealed key transcription factors
that are network hubs and would be critical to determin-
ing meat quality, FA composition and controlling energy
homeostasis. Finally, we experimentally validated some of
the AWM network predictions using real-time PCR gene
co-expression analyses in adipose and liver tissues.
Results
Genotyping data from 48,119 SNPs in 144 backcross
pigs (25% Iberian × 75% Landrace) was employed for
GWAS of fatty acid related traits in the Longissimus
dorsi muscle. For all 15 phenotypes, estimated SNPadditive effects were standardized (z-scores) by subtract-
ing the mean and dividing by the phenotype-specific
standard deviation. After applying a series of selection
criteria (see Methods), a total of 1,096 SNPs were retained
to build the AWM matrix. Correlations between pheno-
types were calculated using AWM columns (standardized
SNP effects across traits) and were visualized as a hier-
archical tree cluster, in which strong positive and negative
correlations are displayed as proximity and distance, re-
spectively (Figure 1). The observed cluster distribution is
in concordance with the physiological similarities and rela-
tionships among FA. Hence, palmitic acid with saturated
FA (SFA), oleic with monounsaturated FA (MUFA), and
linoleic with polyunsaturated FA (PUFA) cluster together
(Figure 1). Linoleic acid and PUFA are clearly differenti-
ated from other FAs. This result can be explained by the
inability of mammals to synthesize linoleic and α-linoleic
FAs, which must be provided by the diet. Gene interac-
tions were predicted using pair-wise correlation analysis
of the SNP effects across pair-wise rows of the AWM.
Hence, the AWM predicted gene interactions based on
significant co-association between SNPs. In the network,
every node represents a gene (or SNP), whereas every edge
connecting two nodes represents a significant interaction.
In total, 111,198 significant edges (or 18.5% of all the pos-
sible edges) between the 1,096 nodes were identified as
significant by the PCIT algorithm [14] (Figure 2A). For
every node we computed the total number of connections
Figure 2 Co-association network based on the AWM approach. (A) Entire network with 1,096 nodes (i.e., genes or SNPs) and 111,198
interactions. The color spectrum ranges from green to red for low and high density, respectively. (B) Subset of the network showing the best trio
of transcription factors: NCOA2, EP300 and FHL2. Node color corresponding with the functional classification of the in-silico predicted target gene
as follows: TF (red), lipid metabolism process (blue), carbohydrate metabolisms (green), development process (orange) and finally, white nodes
represent genes with others functional classification. Node shape indicates classification as: diamond (TF involved in lipid metabolism), triangle
(TF), ellipse (other genes).
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connected nodes and Additional file 1: Table S1 their
positional concordance with fat-related QTL deposited
in the Pig QTL Database.
Gene ontology (GO) and pathway enrichment ana-
lyses were performed to gain insight into the predicted
gene network. Overrepresented GO terms in the network
included: “Cellular component organization” (P = 4.02 ×
10−6, FDR = 3.95 × 10−2), “Cellular component organi-
zation or biogenesis” (P = 7.34 × 10−6, FDR = 3.6 × 10−2),“Cell projection morphogenesis” (P = 9.59 × 10−5, FDR =
9.42 × 10−2), “Fatty acid metabolic process” (P = 5.89 ×
10−4, FDR = 1.03 × 10−2), “Glycerolipid metabolic
process” (P = 1.2371 × 10−3, FDR = 1.66 × 10−2),
“Sphingolipid metabolic process” (P = 7.45 × 10−4,
FDR = 1.16 × 10−2) and “Unsaturated fatty acid biosyn-
thetic process” (P = 2.13 × 10−3, FDR = 2.27 × 10−2).
Additional file 2: Table S2 provides the full list of overrep-
resented GO terms. Pathway analyses revealed an enrich-
ment for “Regulation of actin cytoskeleton (hsa04810)”,
Table 1 Description of the ten most connected nodes in the co-association network
SNP/Gene Illumina Chip SNP Associated Traits Connections Consequence
ALGA0061664 ALGA0061664 3 376 Intergenic variant
SLC30A9 H3GA0024739 1 373 Intronic variant
SEMA3F DIAS0001129 3 370 Intronic variant
ARHGEF2 ASGA0021047 3 368 Downstream variant
NTRK3 MARC0045253 3 367 Intronic variant
ZFHX4 ALGA0025325 1 366 Intronic variant
SLC22A3 ALGA0117149 6 365 Intronic variant
ARMC4 ALGA0059185 4 356 Intronic variant
C9orf171 ASGA0008154 6 355 Intronic variant
PPP2R2A DIAS0004697 5 353 Splice region variant
Ramayo-Caldas et al. BMC Genomics 2014, 15:232 Page 4 of 15
http://www.biomedcentral.com/1471-2164/15/232“Focal adhesion (hsa04510)”, “Pathways in cancer
(hsa05200)”, “Chemokine signalling pathway (hsa04062)”,
“Phosphatidylinositol signalling system (hsa04070)” and
“Inositol phosphate metabolism (hsa00562)” (Additional
file 3: Table S3).
To identify potential regulators of the above-mentioned
pathways and GO categories, we focused on TF found in
the gene network. We applied an information lossless ap-
proach that explored the 64,824 possible trios among the
available 74 TF (see Methods and Additional file 4: Table
S4 for complete list of TF) and identified the TF trio that
spanned most of the network topology with minimum
redundancy. These three TF were: Nuclear receptor coacti-
vator 2 (NCOA2, alias TIF2), E1A binding protein p300
(EP300, alias p300) and four and a half LIM domains 2
(FHL2, alias SLIM-3). Interestingly, the promoter region of
these TF contain binding sites for some well-known TF
that are considered as important regulators of lipid and
carbohydrate metabolism such as: SREBP-1, PPARG,
PPAR-α, HNF1A, HNF4-α, ER-α and GR-α. In the pre-
dicted network, a total of 730 genes show co-association
with the three key TF (Figure 2B). A detailed examination
of the most representative pathways related to these
730 predicted target genes showed a significant over-
representation for “HIF-1 signaling pathway (hsa04066)”,
“Acute myeloid leukemia (hsa05221)”, “Colorectal cancer
(hsa05210)”, “Renal cell carcinoma (hsa05211)” and “Type
II diabetes mellitus (hsa04930)” (Additional file 5:
Figure S1). Admittedly, some of the above-mentioned
GO terms and pathways could have been expected from a
network predicted from GWAS of FA-related phenotypes
and this gives confidence in the reliability of the results.
Others, however, were unexpected and might lead to new
insights on FA physiology.
Experimental validation: From co-association to
co-expression analysis in liver and adipose tissues
The expression of the three TF across Longissimus dorsi
muscle (LD), adipose and liver tissues was explored. Inconcordance with previous results suggesting that highly
connected TF are in general broadly expressed across
tissues [15], the three TF were expressed across all the
studied tissues. Further, a comparison between Iberian
and Landrace pig breeds revealed significant increase fold
changes (FC) in the liver of Iberian pigs for the expression
of NCOA2 (FC = 1.56, P < 0.01) and EP300 (FC = 1.23,
P < 0.05) (Figure 3).
The expression patterns of 43 genes in liver and 40
genes in adipose tissue were successfully measured across
55 backcross animals. In liver, the expression data of
twelve additional genes were also included in the co-
expression analysis (see Methods). Co-expression analysis
revealed highly connected networks in both liver and adi-
pose tissue, suggesting strong functional interconnections
among the studied genes. Topology of liver co-expression
network showed 55 nodes connected by 425 edges
(Additional file 6: Figure S2A) and in adipose tissue 40
nodes and 261 edges were observed (Additional file 6:
Figure S2B). Network parameters such as average de-
gree (Deg) and average distance (AvDG) were slightly
higher in liver co-expression network compared to
adipose tissue network (DegLiver = 15.45 AvDG = 1.81 vs
DegAdipose = 13.05 and AvDG = 1.75). Based on network
centrality, the relevance of individual genes differs within
each network. For example, topological properties of the
liver co-expression network suggest an important role
for ARNT in the regulation of hepatic lipogenic and
glucoconeogenesis activity, and these findings agree
with published results [16,17]. It should be noted that
BCL9 showed the highest centrality value in the liver
co-expression network (Additional file 6: Figure S2A).
In addition, degree analysis showed that BCL9, EP300,
PBX1, SIRT1, PIP5K1A and ARNT were the most cen-
tral genes in the liver co-expression network. However,
in the adipose co-expression network, degree analysis
suggested that ANK2, NCOA2, SIRT1, EIF4E, HMBOX1
are the most central genes (Additional file 6: Figure S2B).
When analysing a sub-network of the liver co-expression
Figure 3 Results of the liver differential expression analysis comparing the best TF trio in the Iberian and Landrace breeds.
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the adipose co-expression network, five genes (BCL9,
EP300, PBX1, PIP5K1A, and SIRT1) were still the most
central genes and this finding underscores their relevant
role in the function and structure of the liver co-
expression network.
Beyond the study of the topological properties of the
liver and adipose tissue co-expression networks, we were
concerned with those, if any gene interactions predicted
via SNP co-association were corroborated through co-
expression analyses. In line with recent results in yeast
[18], we observed that interacting loci could jointly regu-
late the co-expression patterns of pairs of genes. For the
first time in a not model species, co-expression analyses
confirmed gene-gene interactions predicted based on
SNP co-association. However, the magnitude of this val-
idation varied in a tissue-specific manner. For instance,
with respect to the liver module formed by 48 AWM
nodes and 359 edges (based on co-association analysis) we
observed that 28.9% (104/359) of the predicted gene-gene
interactions were validated by the co-expression results.
Whereas in the adipose tissue, the observed percentage of
the AWM validated interactions was slightly higher repre-
senting 33.0% of the possible combinations (Figure 4B).
When we limited this comparison to the intersecting 39
genes included in both co-expression networks, the pro-
portion of the AWM gene-gene interactions validated
in liver (29.5%) was still lower than in adipose tissue
(33.0%). Comparing both networks, we observed that
approximately 35.7% (or 30 out of 84) of the interac-
tions validated in the adipose tissue were also validated
in the liver co-expression analysis (Additional file 7:
Table S5). Interestingly, these always co-associated and
co-expressed genes belong to biological processes re-
lated to lipid metabolism including: Negative Regulationof Fat Cell Differentiation (INSIG1, TCF7L2, ZFPM2),
Androgen Receptor Signalling Pathway (EP300, FHL2,
NCOA2), Response to Hormone Stimulus (ABCC5,
ANGPT1, FABP3, EP300, SORT1, FHL2) and Lipid
Metabolic Process (PBX1, INSIG1, FABP3, FDFT1,
PIP5K1A, MAX, AASDH).
When we focused on the best TF trio, we observed
that 60.8% (or 14 out of 23) of the interactions of
NCOA2 predicted by the AWM co-association network
were corroborated in the co-expression network of the
adipose tissue. This percentage dropped to 34.6% (or 9
out of 26) in the co-expression network of the liver tissue.
For EP300, 44.4% (or 4 out of 9) of the AWM predicted
interactions were observed in the adipose co-expression
network and 41.6% (5 out of 12) in the liver co-expression
network. Finally, for FHL2 we observed the lowest per-
centage of validated interactions: 20.0% (or 2 out of 10) in
adipose tissue and 14.3% (2 out of 14) in liver (Table 2).
Discussion
Molecular processes controlling FA metabolism are highly
interconnected and linked with related pathways, such as
lipid, carbohydrate and energy metabolism. In fact, FA are
a major energy source and together with several factors,
such as total energy intake, dietary fat/carbohydrate ratio,
or glucose and/or insulin concentration, regulate de novo
lipogenesis [19,20]. As a consequence, it is expected that
at the selected threshold (P < 0.035) our best trio of TF
(NCOA2, EP300, FHL2) show co-association with a large
number of genes and other TF relevant for lipid, carbo-
hydrate and energy metabolism. For instance, 39 of the
predicted target genes via SNP co-association (Additional
file 8: Table S6) have been recently reported in two large-
scale meta-analysis studies for plasma lipids in humans
[21,22]. Interestingly, many of these genes, including our
Figure 4 Connections from the co-association network that were confirmed by the co-expression network in liver (A) and adipose
(B) tissue. Nodes color relate to the functional classification of genes as follows: TF (red nodes), lipid metabolism (blue nodes), carbohydrate
metabolism (green), development process (orange) and white nodes represent genes with others functional classification. The size of the nodes
corresponding to the best trio of transcription factors (NCOA2, EP300 and FHL2) has been enlarged to facilitate their location.
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Table 2 Concordance validation between the co-association and the co-expression networks for the best TF trio and in
adipose and liver tissues
Tissue TF Connections in the AWM
co-association networkA
Connections in the qPCR
co-expression networkA
Validated connections % Validation
Adipose NCOA2 23 21 14 60.8
EP300 9 19 4 44.4
FHL2 10 9 2 20.0
Liver NCOA2 26 18 9 34.6
EP300 12 28 5 41.6
FHL2 14 13 2 14.3
AConnections deemed significant according to the PCIT algorithm.
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missed by traditional single-trait GWAS due to the lack of
an acceptably significant association level (i.e. P > 0.05
after correction for multiple testing). As noted before [12]
and confirmed by this study, AWM points to new candi-
date genes, TF and gene interactions via exploring SNP
co-associations across multiple traits beyond the one-
dimensional approach for identifying genes affecting single
traits. However, results should be interpreted with caution
due to the limited sample size used in our study (144 pigs),
which reduces the power to identify small effects and may
introduce spurious results. Therefore, these TF might
regulate other important genes for IMF FA composition
not represented in this network and false positive results
may be included in the network. However, only the SNPs
associated with a large number of phenotypes were in-
cluded in the AWM analysis and, due the multi-trait
nature of the AWM methodology, the probability that
the same SNP was associated with several phenotypes
by chance is much lower than the probability of being
associated with a single phenotype.
In the predicted network, NCOA2, a key TF regulating
energy homeostasis [20,23] and adipogenesis [24], showed
co-association with a total of 326 genes, including relevant
TF and genes associated with lipid and carbohydrate me-
tabolisms, such as PROX1, PBX1, ARNT, MYB, MTF2,
TCF7L1, SCD5, ABCC2, INSIG1, ACACB, FABP4, FABP3,
ME1, AASDH, ABCC5 and SORT1. A role for PROX1 in
the control of energy homeostasis has been proposed [25].
Moreover, association of SNPs mapped to PROX1 and
SLC30A8 with fasting glucose levels and increased risk for
T2D has been reported in humans [26]. Both PROX1 and
SLC30A8, together with other T2D risk loci (IL6R,
TCF7L2, HNF1A) and 21 genes reported as associated
with plasma lipids in humans [22] were predicted as target
genes of NCOA2 in our study. Co-expression analysis in
adipose tissue validated 60.8% of the NCOA2 co-
association target genes, including INSIG1 (rco-expression =
0.68), FDFT1 (rco-expression = 0.70), SETD2 (rco-expression =
0.59) and ABCC5 (rco-expression = 0.65). In liver, 34.6% of
the predicted targets of NCOA2 were validated, includingthe above-mentioned PROX1 (rco-expression = 0.48), HNF1A
(rco-expression = 0.56) and TCF7L2 (rco-expression = 0.50). It
should be noted that previous studies in pigs show a cor-
relation between NCOA2 expression (r = 0.605, P < 0.01)
and IMF content of LD muscle [24]. Also, NCOA2 was
reported as modulating an AWM-network predicted for
puberty in cattle [27], which included fat deposition
measurements as traits related to puberty. Furthermore,
knockout NCOA2 −/− mice are protected against obes-
ity, showing lean phenotype and decreased expression
of genes involved in the uptake and storage of FA [20].
A decreased expression of genes required for FA syn-
thesis in liver tissue of NCOA2 −/− mice was observed
[28]. In agreement with these previous results and the
phenotypic difference in fat deposition between Iberian
and Landrace breeds, a significant higher activity of
NCOA2 in the liver of Iberian pigs was detected (FC =
1.56, P < 0.01) relative to Landrace pigs (Figure 3).
Another TF predicted as critical for FA regulation was
EP300, which encodes the adenovirus E1A-associated cel-
lular p300 transcriptional co-activator protein. It functions
as histone acetyltransferase that regulates transcription by
chromatin remodelling. Via histone acetyltransferase ac-
tivity, EP300 regulates the transcription of liver X receptor
(LXR) [29]. EP300 is also required for adipocyte differenti-
ation through the regulation of peroxisome proliferator-
activated receptor gamma (PPARG) [30]. Remarkably,
EP300 has been reported as transcriptional co-activator of
estrogen receptor (ER), hepatocyte nuclear factor 4 α
(HNF4-α), aryl hydrocarbon receptor nuclear translocator
(ARNT) and hepatocyte Nuclear Factor-1 α (HNF1A)
[31-33]. All these above-mentioned TF co-regulated by
EP300 (PPARG, LXR, HNF4, HNF1A, ER, ARNT) influ-
ence lipid and carbohydrate metabolisms and have been
extensively studied in this context [17,34-41]. Among the
180 AWM-predicted target genes for EP300, there are 30
genes known to be involved in lipid metabolism including
ARNT a member of the HIF-1 pathway. ARNT is a rele-
vant TF regulating hepatic gluconeogenesis and lipogenic
gene expression [16]. Interestingly, we observed a signifi-
cant co-expression between ARNT and EP300 (r = 0.61) in
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carbohydrate and lipid metabolism were predicted as
EP300 AWM-target genes. These included: ADCY2,
MMP9, ECHS1, ARRB1, EIF4E, ANK2, NR2E1, SLC2A6,
SLC5A2, LEP, ELOVL6, MTTP, ACSM5, UCP2 and
CYP2E1 (for a full list see Additional file 9: Table S7).
Similarly to NCOA2, a significant higher expression of
EP300 in the liver of Iberian pigs was detected (FC = 1.23,
P < 0.05) in comparison with Landrace pigs (Figure 3).
Our results, predicting targets for EP300 and studying
their co-expression contributes to the knowledge on
lipid and carbohydrate metabolism. It is well known
that TF require co-regulators to modify and epigeneti-
cally remodel chromatin structure to facilitate the
basal transcriptional machinery. EP300 is a chromatin
remodeling gene opening new possibilities to study the
roll of epigenetic modifications in the regulation of
pork meat quality and the molecular control of energy
homeostasis.
The third key TF was FHL2, an evolutionarily con-
served gene that can interact with an important range of
proteins from different functional classes, including re-
ceptors, signal transducers, TF and cofactors [42]. FHL2
plays an important role as molecular transmitter linking
various signalling pathways to transcriptional regulation.
For instance, FHL2 is involved in the co-activation of
human androgen receptor (AR), ER and peroxisome
proliferator-activated receptor alpha (PPARα) [42-44]. In
addition, FHL2 mediates interaction with β-catenin and
promotes myoblast C2C12 differentiation in mice [45].
The gene B-cell CLL/lymphoma 9 (BCL9), an activator
of the Wnt/β-catenin [46] and Wingless-type MMTV
integration site family, member 4 (WNT4) was among
the 251 targets predicted for FHL2 in our network. The
growth factor WNT4 is a member of the Wnt signaling
pathway involved in developmental processes and rele-
vant for gonad development and sex-determination [47].
Liver expression analyses provided supporting evidence
for the predicted interaction between FHL2 and WNT4,
as a significant co-expression (r = 0.44, P < 0.001) was
observed. Other genes and TF associated with develop-
ment process, lipid and carbohydrate metabolism, such
as FHL5, MYO1E, MYB, RORC, JARID2, ZFHX4, WNK1,
LIPC, CREB5, CDC42, ACSL1, FABP5, ABCB11, FLT1 and
HTR2A were also predicted as targets of FHL2 according
to the co-association network. FHL2 was not differentially
expressed in the comparison between Iberian and Land-
race pigs. Also, FHL2 showed a proportion of validated
interactions in the co-expression analysis (20% adipose
tissues and 14.3% in liver) lower than for the other two
TF, NCOA2 and EP300. These somewhat less promising
results could be a consequence of the tissue-specific activ-
ity of FHL2, as it has been reported for the co-activation
of AR [43].Although, some gene to gene interactions predicted by
the AWM approach were not corroborated by the co-
expression analysis, the possibility of these interactions
occurring in other spatial temporal and/or tissues cannot
be ruled out, or indeed manifesting their joint effect
through other means than co-expression. TF and their
target genes interact in a temporal and tissue dependent
manner, so the examination of networks spanning mul-
tiple tissues is critical to highlight interactions that could
otherwise be unknown from individual tissue analysis
[48]. In spite of this tissue/time limitation, two of the
three TF from the best trio (EP300 and NCOA2) showed
higher than average centrality values in both liver and
adipose tissue co-expression networks. Moreover, we ob-
served a significant co-expression between NCOA2 and
EP300 in the liver network with some other TF consid-
ered master regulators of the lipid metabolism. For in-
stance, NCOA2 was significantly co-expressed with PPARα
(r = 0.39, P < 0.01), HNF1A (r = 0.56, P < 0.001) and HNF4α
(r = 0.36, P < 0.01), and EP300 was co-expressed with
PPARD (r = 0.38, P < 0.01) and HNF1A (r = 0.64, P < 0.001)
(Additional file 6: Figure S2 A, B). The liver plays a central
role in maintaining overall energy balance by controlling
lipid and carbohydrate metabolism. In pigs, the liver is the
primary site of de novo cholesterol synthesis and fatty acid
oxidation and, together with adipose tissue, has a crucial
role in regulating lipid metabolism [49,50]. All these obser-
vations, together with the higher expression of NCOA2
and EP300 observed in the liver of the Iberian pigs com-
pared with Landrace pigs, suggest a relevant role of these
genes in the hepatic transcriptional regulation of lipid me-
tabolism in pigs.
Overall, our GWAS and network predictions, sup-
ported by literature and co-expression analysis in liver
and adipose tissue, suggest a co-operative role for the
three TF (NCOA2, EP300, FHL2) in the transcriptional
regulation of IMF, FA composition and the control of
energy homeostasis in pigs. We hypothesize that these
TF mediate a highly inter-connected regulatory cas-
cade including pathways such as HIF-1, AR, ER and
Wnt/β-catenin that seem pivotal for lipid metabolism.
The role of these pathways in the transcriptional regu-
lation of lipid metabolism is a subject of intense stud-
ies [17,38,39,51-54]. A functional cooperation between
the three TF in the modulation of these pathways is
evident from our results and supported by literature
evidence. For example, according to String database
[55,56] (http://string-db.org/), experimental data con-
firmed that protein-protein interaction exists among,
EP300, NCOA2, FHL2, AR and ESR1 (Additional file 10:
Figure S3). In addition, EP300 and NCOA2 take part on
the AR and ER pathways and both, NCOA2 and FHL2
are AR co-regulators [43,57,58]. Studying the combined
effect of NCOA2, EP300, and FHL2 in the regulation of
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pathways.
The most overrepresented pathway corresponding to
the 730 AWM-predicted target genes of the three TF
was HIF-1 (Additional file 5: Figure S1). The HIF-1
pathway is central to adaptive regulation of cellular energy
metabolism; by regulating the expression of glycolytic en-
zymes and hepatic lipid metabolism [17,54,59,60]. Our
liver co-expression analysis supports previously reported
evidence [16] for the relevance of ARNT gene (member of
HIF pathway) in the hepatic lipogenic gene expression.
Additionally, HIF-1α, which is another member of HIF
pathway and β-catenin co-ordinately enhance AR trans-
activation. The interaction between β-catenin and both
HIF-1 and AR pathways has been documented [61-63].
Moreover, β-catenin is a ligand-dependent co-activator
of AR and a functional cooperation in the synergistic
activation of AR-mediated transcription among EP300,
FHL2 and β-catenin have been reported [64]. Ours re-
sults showing the interactions between the three key TF,
recapitulate these pathways interactions that are known
mammalian biology, extending its significance to pigs.
Conclusions
In summary, our results suggest that common genetic var-
iants mapped to (or in linkage disequilibrium with) EP300,
FHL2 and NCOA2 together with other candidate genes
including ARNT, BCL9, SIRT1, PBX1, PROX1, HNF1A,
SLC30A8, TCF7L2 and ANK2 modulate lipid metabolism
and control energy homeostasis in pigs. Furthermore, epi-
static predicted interactions between TF and their target
genes are likely to contribute to the complex inheritance
of FA composition and related polygenic traits (lipid me-
tabolism and energy homeostasis). It is generally accepted
that metabolic diseases such as obesity and T2D are linked
to disturbance of energy homeostasis or homeostatic im-
balance. It should be noted that among the 730 predicted
target genes, an overrepresentation of genes from the T2D
pathway was observed (Additional file 5: Figure S1). Also,
39 of the 730 genes are known to control plasma lipid
content in humans [21,22].
Further studies will be required to elucidate the specific
cellular and molecular processes of interaction among the
three TF and its target genes that determine FA compos-
ition and control energy homeostasis in pigs. The implica-
tions of research in this area are broad, ranging from
applications from pork meat quality to modeling mammal
biology.
Methods
Phenotypic traits, animals and genotypes
Data from 144 pigs (25% Iberian × 75% Landrace), repre-
senting 26 full-sib families, from backcrossing five F1
males with 26 Landrace sows was utilized. Details aboutthe management conditions and the phenotype informa-
tion have been previously reported [65-67]. For this
study and based on an previous principal components
analysis [66] we selected 15 of the total 48 traits repre-
senting the most informative phenotypes within the
dataset. Nine of the 15 traits were related to IMF fatty
acid (FA) composition in LD muscle, seven correspond
to indices of FA metabolism and the last one is the IMF
percentage (Additional file 11: Table S8). The Porcine
SNP60K BeadChip (Illumina) [68] was used to genotype
a total 197 pigs, including the 144 phenotyped animals
and the founder population. Quality control excluded
SNPs with minor allele frequency < 5% and with call
rate < 95%. A subset of 48,119 SNPs were retained for
subsequent analysis, in addition, previously detected
polymorphisms in the MTTP, FABP4, FABP5, and
ELOVL6 genes were also tested [67,69,70]. The genomic
coordinates of the SNP correspond to the Sus scrofa
genome sequence assembly (Sscrofa10.2, August 2011)
[71] and were annotated using as reference the pig assem-
bly 10.2 [ftp://ftp.ncbi.nlm.nih.gov/genomes/Sus_scrofa/
GFF/].
Ethics statement
Animal care and procedures were performed following
national and institutional guidelines for the Good Experi-
mental Practices and approved by the Ethical Committee
of the Institution (IRTA- Institut de Recerca i Tecnologia
Agroalimentàries).
Statistical analysis
The GWAS was performed using Qxpak 5.0 software [72].
The additive effect of a SNP on each trait was estimate by
mixed model [73,74] following the model:
yij ¼ Xβþ Zuþ sj;k þ eij;
where: yij represents the vector of observations from the
ith pig at the jth trait ; X is the incidence matrix relating
fixed effects in ß with observation in yij; Z is the inci-
dence matrix relating random additive polygenic effects
in u with observation in yij; sj,k represents the additive
association of the kth SNP on the jth trait and eij is the
vector of random residual effects. Fixed effects included
in ß were, sex (two levels), batch (five levels) and carcass
weight as covariate. Polygenic effects were treated as ran-
dom and distributed as N(0, Aσu) where A is a numerator
of kinship matrix. Then, the allele substitution effect of
the ith SNP on the jth trait was z-score standardized and
employed to constructing the AWM [12].
An R script, available from the authors, was written to
automate the process of building an AWM. Palmitoleic
acid (C16:1 (n-7)) was used as the key phenotype and
the procedure described by Fortes and colleagues [12]
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specifically regarding the P-value threshold for selecting
SNP from GWAS. The P-value threshold was chosen by
exploring the sensitivity of the data instead of simply
accepting the nominal P < 0.05. We took advantage of
the biological knowledge concerning TF related to the
analyzed traits and used it as a priori information.
In essence, instead of applying a hard-coded nominal
P-value of, for instance, 0.05 or 0.01 or 0.001, we employed
a knowledge-based approach to identify the P-value
threshold at which the information content, in terms of
fatty acid regulation, is maximized. To this effect, we
mined the literature and relevant databases to compile a
list of 340 TF of which 34 were known to be related to
FA metabolism. The distribution of these 34 TF relative
to the entire set of 340 was explored at various P-value
thresholds. The P-value threshold that maximized the
number of FA-related TF was used as the optimal P-
value to apply when developing the Association Weight
Matrix. Quite importantly, others in the past have
employed a knowledge-based approach to identify the
critical P-value threshold. More recently, and in the
context of GWAS, Yang et al. [75] used an approach
similar to ours to find the P-value that maximise the
correlation between the proportion of significant SNPs
and the heritability across 47 traits.Figure 5 Sensitivity analysis of the 34 lipid-related TF at different P-v
340 TF included in the dataset.In detail, the process for choosing the threshold was as
follows:
Step1: A total of 340 TF were located within 2.5 Kb of
a SNP and therefore included in the initial dataset. For
all these TF included in our dataset, those that are well
known key regulators of the lipid metabolism were
initially selected.
Step2: For each gene, those involved in the lipid
metabolism and also reported in the census of human
TF by Vaqueriza et al. [76] were included.
Step3: The Human Protein Reference Database
(HPRD) and the Biomolecular Object Network
Databank (BIND) were mined. Then other TF that
have been reported to interact with some of the TF
retained in the two previous steps were selected. After
these first 3 steps, a total of 34 TF were retained
(Additional file 12: Table S9).
Step4: Subsequently we compare the distribution of the
34 TF at different P-values from P = 1 to P = 10−4
versus the distribution of the total number of TF
included in the AWM (340). As a result, we have
chosen P < 0.035 as the threshold. This specific P-value
maximizes the difference between both groups of TF
(Figure 5), imposing an informed bias towards lipid
metabolism to the network.alues (form P < 1 to P < 10−4) against the distribution of the total
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of SNPs for building AWM continued. Those SNPs that
were either associated (P < 0.035) with palmitoleic acid
or with any ≥ 3 traits, and were located either ≤ 2,500 bp
to or ≥ 850 kb from the nearest annotated gene (Sscrofa10.2
assembly), were selected to build the AWM matrix. Per-
mutMatrix software [77] was employed to visualize
hierarchical clustering of traits (AWM columns) and
genes (AWM rows) using Euclidean distance and the
Average linkage method. To identify and report gene-
gene or gene-SNP interactions we used PCIT algorithm
[14]. Cytoscape software [78] was used to visualize the
gene network and also to perform overrepresented GO
terms analysis, using BiNGO plugin [79]. Node centrality
values and network topological parameters were calculated
using CentiScaPe plugin [80]. Pathway enrichment analysis
were performed using FATIGO tool form BABELOMICS
[81,82]. Further, pathways analyses of the 730 predicted
target genes (co-associated with the key TF) were per-
formed using ClueGO, Cytoscape plugin [83]. Pathway
information was retrieved from the KEGG (http://www.
genome.jp/kegg/) and BioCarta (http://www.biocarta.com/)
databases. In all cases, the cut-off for considering a signifi-
cance overrepresentation was established by Benjamini &
Hochberg multiple testing correction of the P-value
(FDR < 0.05) [84].
Expression and co-expression analysis
In order to provide supporting evidence for the in-silico
AWM-network predictions we obtained and explored
gene expression data by reverse transcription quantita-
tive Real-Time PCR (RT-qPCR). The expression pattern
of the 3 Key TF (NCOA2, EP300, FHL2) in LD muscle,
liver and adipose tissues was tested in two phenotypic-
ally divergent breeds for fat deposition traits (Iberian
and Landrace which are also the founders of our studied
population, five animals per breed). Finally, liver and adi-
pose co-expression analyses of 55 (43 from the present
study, and twelve: ACSM5, APOA2, ARNT, CYP7A1,
FABP5, FADS3, HNF4a, LIPC, MTTP, PPARA, PPARD
and ELOVL6 genes from Ballester et al., 2013 submitted)
and 40 genes, respectively, were performed using the
PCIT algorithm [14] in 55 backcross animals. Since sex
differences in liver transcriptome have been reported
[85] only females were considered in the co-expression
analyses of both tissues.
From the 55 genes explored in the liver co-expression
analysis, 48 were present in the AWM network. The
remaining seven were incorporated due to their bio-
logical relevance, including three well-know TF related
to lipid metabolism (PPARα, PPARD, HNF4α) and four
genes related to lipid metabolism (SIRT1, FADS3, APOA2,
CYP7A1). Similarly, from the 40 genes employed in the
adipose co-expression analysis, 39 were present in theAWM network. The one gene out, SIRT, was also included
due to its relevant controlling lipolysis [86,87] and pro-
moting fat mobilization in white adipose tissue [88].
Total RNA was obtained from liver, muscle and adi-
pose tissues using the RiboPure kit (Ambion), following
the manufacturer’s recommendations. RNA was quanti-
fied using the NanoDrop ND-1000 spectrophotometer
(NanoDrop products) and the RNA integrity was assessed
by Agilent Bioanalyzer-2100 (Agilent Technologies). Ap-
proximately, one microgram of total RNA was reverse-
transcribed into cDNA using the High-Capacity cDNA
Reverse Transcription kit (Applied Biosystems) in 20 μl of
reactions, following the manufacturer’s instructions.
To analyze the expression pattern of the 3 key transcrip-
tion factors, an ABI PRISM 7900 Sequence Detection Sys-
tem (Applied Biosystems) in combination with FastStart
Universal Sybr green master (Rox; Roche Applied Science)
was used. PCR amplifications were performed in a total
reaction volume of 20 μl containing 5 μl of cDNA diluted
1:25. All primers were used at 300 nM. The thermal cycle
was 10 min at 95°C, 40 cycles of 15 s at 95°C and 1 min at
60°C. A dissociation curve was drawn for each primer pair
to assess the specificity of the amplification. Three refer-
ence genes (ACTB, HPRT1, TBP) frequently used in RT-
qPCR experiments were tested as endogenous controls.
Using the GeNorm software [89], the ACTB and TBP
genes were selected as the best endogenous controls for
all tissues. After ensuring the possibility to use the 2-ΔΔCT
method [90], data was analyzed using the RQ manager
v1.2.1 and the DataAssist™v3.0 softwares (Applied Biosys-
tems). The 2-ΔCT values were used to compare our data.
The 48.48 microfluidic dynamic array IFC chip (Fluidigm)
was used to analyze the expression of 48 genes (44 tar-
get genes and 4 reference genes) in liver and adipose
tissue of 55 backcross animals belonging to the same
population in which the GWAS was performed. Two μl of
1:5 diluted cDNA was pre-amplified using 2X Taqman
PreAmp Master Mix (Applied Biosystems) and 50 nM
of each primer pair in 5 μl reaction volume, according
to the manufacturer’s directions. The cycling program
was 10 min at 95°C followed by 16 cycles of 15 s at 95°C
and 4 min at 60°C. At the end of this pre-amplification step,
the reactions were diluted 1:5 (diluted pre-amplification
samples). RT-qPCR on the dynamic array chips was con-
ducted on the BioMark™ system (Fluidigm). Five μl sample
pre-mix containing 2.5 μl of SsoFast EvaGreen Supermix
with Low ROX (Bio-Rad), 0.25 μl of DNA Binding Dye
Sample Loading Reagent (Fluidigm) and 2.25 μl of diluted
pre-amplification samples (1:16 or 1:64 from the diluted
pre-amplification samples from liver and backfat, re-
spectively), as well as 5 μl assay mix containing 2.5 μl
of Assay Loading Reagent (Fluidigm), 2.25 μl of DNA
Suspension Buffer (Teknova) and 0.25 μl of 100 μM
primer pairs (500 nM in the final reaction) were mixed
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The thermal cycle was 60s at 95°C followed by 30 cycles
of 5 s at 96°C and 20s at 60°C. A dissociation curve was
also drawn for each primer pair.
Data was collected using the Fluidigm Real-Time PCR
analysis software 3.0.2 (Fluidigm) and analyzed using the
DAG expression software 1.0.4.11 [91] applying the rela-
tive standard curve method (see Applied Biosystems user
bulletin #2). Standard curves with a four-fold dilutions
series (1/4, 1/16, 1/64, 1/256, 1/1024) of a pool of 10
cDNA samples were constructed for each gene to ex-
trapolate the quantity values of the studied samples. The
PCR efficiencies were almost 100% in both tissues for all
the assays (Additional file 13: Table S10) with low coeffi-
cients of inter-assay variation of threshold cycle (<2.4%
in liver and <3.5% in adipose tissue). Of the four en-
dogenous genes tested (ACTB, B2M, HPRT1, TBP),
ACTB and TBP were the genes with the most stable ex-
pression [89] in both tissues. The normalized quantity
values of each sample and assay were used to compare
our data.
All the primers used in this study were designed using
PrimerExpress 2.0 software (Applied Biosystems) and are
shown in Additional file 13: Table S10. Prior to perform
the Fluidigm Real-Time PCR, all the assays were tested for
PCR specificity in an ABI PRISM 7900 Sequence Detec-
tion System (Applied Biosystems) using two-fold dilutions
(1/20, 1/200) of a pool of ten cDNA samples and a minus
RT control to check the presence of DNA contamination.
Melting curve analysis was performed for all the assays.
Data availability
The relevant information and full data sets are included
as additional files.
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connected nodes and QTL deposited in the pig QTL database for fatness
related traits.
Additional file 2: Table S2. Overrepresented GO terms indentified in
the network using BinGO Cytoscape plugin.
Additional file 3: Table S3. Overrepresented pathways identified with
Fatigo.
Additional file 4: Table S4. Complete list of the 74 available TF in the
AWM.
Additional file 5: Figure S1. Overrepresented pathways related to the
730 AWM-target genes according ClueGO results. ClueGO visualizes the terms
in a functionally grouped annotation network, reflecting the relationships
between the terms (based on the similarity of their associated genes).
The size of the nodes reflects the statistical significance of the terms.
The group leading term is the most significant term of the group.
Additional file 6: Figure S2. Gene co-expression network in liver (A)
and adipose (B) tissue. Nodes color relate to the functional classification
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Additional file 8: Table S6. List of the 39 AWM-predicted target genes
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metabolism predicted as target genes of EP300.
Additional file 10: Figure S3. Protein-protein interaction among EP300,
FHL2 and NCOA2 with ESR1 and AR inferred from String database.
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